- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03026621
Examining the Change in Microbiome Diversity and Urine Metabolites After Lignite Extract Use
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
OBJECTIVES:
The purpose of this study is to determine whether or not 'Restore' lignite extract mineral supplement impacts the microbiome composition of the mouth and gut. Additionally, participant urine samples will be examined to determine whether or not 'Restore' mineral supplement impacts the composition urine biomarkers and toxins.
BACKGROUND & RATIONALE There is mounting evidence that the composition of the microbiome can change quickly. Unpublished case reports have shown significant shifts in the microbiome when participant's diet changes from a high carbohydrate to a high fat diet. Clinically, the use of 'Restore' mineral supplement has led to the bulking of stool in people using it for the first time within one or two days of first dose, further indicating a change in the gut microbiome.
Given these observations, this clinical trial was designed to examine how taking 'Restore' mineral supplement may impact the microbiome by examining the gut bacteria composition at two days, and again at two weeks. Our hypothesis is that taking Restore alone can lead to a quantifiable shift in the diversity of the microbiome as measured by the Simpson's Diversity Index, a mathematical measure of species diversity in a community. This index provides more information about community composition than simply species richness by also taking into account the relative abundances of different species.
There is also evidence that Restore mineral supplement can impact urine composition. Specifically, we will be examining the change in the presence of zonulin, glyphosate, creatinine-albumin ratio, and stem cells.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: David Roberts, MPH
- Phone Number: 844 432-5488
- Email: droberts@seraphicgroup.com
Study Locations
-
-
Virginia
-
Charlottesville, Virginia, United States, 22902
- Recruiting
- Biomic Sciences
-
Contact:
- David Roberts, MPH
- Phone Number: 844-432-5488
- Email: droberts@seraphicgroup.com
-
Principal Investigator:
- David Roberts, MPH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- People over 18 and under 80 who have never taken Restore gut supplement
Exclusion Criteria:,
- pregnant women, prisoners, people with primary bowel disorder or who have taken antibiotics over the last four weeks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo
This will be an herbal tea the looks similar to the control.
|
This is an herbal tea that will look like the control
Other Names:
|
Experimental: Lignite Extract
This will be the Restore gut supplement
|
The study design is a double-blind case-control trial, whereby half of the participants will be "cases" and will be asked to take 5mL 'Restore' mineral supplement three times each day.
The other half of the participants will be "controls" and will be asked to take 5mL of a placebo three times each day.
Both the study leader and the participants will be blinded to who receives Restore and who receive placebo.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Intestinal Microbiome
Time Frame: 2 weeks
|
Next generation genetic sequence will be taken
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oral Microbiome
Time Frame: 2 weeks
|
Next generation genetic sequence will be taken
|
2 weeks
|
Urine metabolies
Time Frame: 2 weeks
|
Urine glyphosate, CD34, zonulin, creatine-albumin ratio and a urine analysis panel
|
2 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: David Roberts, Seraphic Group
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 104
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Microbiome
-
University Hospital, AntwerpRecruitingSkin Microbiome | Vaginal Microbiome | Saliva MicrobiomeBelgium
-
ProgenaBiomeRecruitingGastrointestinal Microbiome | Gut MicrobiomeUnited States
-
University of California, DavisCompletedGut Microbiome | Skin Microbiome | Gut Lipidome | Skin Lipidome | Blood LipidomeUnited States
-
University of California, Los AngelesCompleted
-
University of California, DavisCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed
-
University of AarhusAarhus University Hospital; University of Copenhagen; Arla FoodsActive, not recruitingBreast Milk Collection | Infant Gut Microbiome | Human Milk/Breastfeeding | Human Milk MicrobiomeDenmark
-
University Medical Center GroningenCompleted
-
The Gut Microbiome Center (Centar za crijevni mikrobiom)University of ZagrebCompletedGastrointestinal MicrobiomeCroatia
-
University of GlasgowActive, not recruitingGastrointestinal MicrobiomeUnited Kingdom
Clinical Trials on Herbal tea
-
Aberystwyth UniversityTeTrimTeas CyfActive, not recruitingObesity | Well-beingUnited Kingdom
-
Medical University of South CarolinaTraditional Medicinals CorporationCompletedLactationUnited States
-
Composite Interceptive Med ScienceComposite Interceptive Med-Science Laboratories Pvt LtdUnknown
-
Taichung Tzu Chi HospitalRecruitingNon-alcoholic Fatty Liver DiseaseTaiwan
-
University of ArizonaUnited States Department of DefenseCompletedLung Cancer Prevention
-
National Cheng Kung UniversityBuddhist Tzu Chi General Hospital; E-DA Hospital; Tzu Chi UniversityNot yet recruitingQuality of Life | Dementia | Caregiver Burden
-
Transtimulation Research, IncNational Center for Complementary and Integrative Health (NCCIH); Texas Tech... and other collaboratorsCompleted
-
Dr.Ruba MusharbashUnknown
-
Instituto Politécnico de BragançaRecruiting
-
University of Missouri-ColumbiaCompletedGlucose | Blood Sugar; High | Glucose Metabolism Disorders (Including Diabetes Mellitus)United States